
Pediatric Sedation Statistics (2026): Usage, Safety, and Adverse Events in Children
Pediatric dental sedation is common and rising, with about 8% of children's dental visits in a large dataset involving sedation medications and roughly 90% of those being mild sedation. For most children it is safe, yet the data is clear that risk is real, age-dependent, and concentrated in respiratory events. The statistics below cover how often sedation is used in children, how safe it is, and which children face the highest risk.
- A 2026 analysis found about 8% of 37.2 million pediatric dental visits involved sedation medications, covering roughly 1.4 million children.
- About 90% of those sedations were classified as mild, with smaller shares moderate and deep.
- Roughly 4% of pediatric sedation encounters were followed by an ER visit, urgent care, or hospitalization within a week, about 1 in 27.
- A registry of 7,041 office-based cases found no deaths or serious complications, showing strong safety in well-run settings.
- Reported adverse event rates range widely from 8% to 47.5%; the most serious are respiratory, with laryngospasm around 0.50%.
- Higher risk was found in children aged 12 to 17, those with chronic conditions, and, in other research, very young children.
- Most serious adverse events are considered potentially avoidable, underscoring the value of monitoring and patient selection.
What's in This Guide
01 How Often Children Are Sedated
Sedation is a common part of pediatric dentistry, driven by the reality that many young children cannot cooperate with treatment, especially when extensive caries requires significant work. The most comprehensive recent picture comes from a large 2026 analysis of insurance claims data.
In a June 2026 study published in the Journal of the American Dental Association, researchers analyzed MarketScan commercial and Medicaid data and found that of more than 37.2 million pediatric dental visits between 2014 and 2019, over 2.8 million, about 8%, involved high-risk sedation medications such as benzodiazepines, barbiturates, and opioids, covering roughly 1.4 million children with a median age of 8. Encouragingly, the great majority, about 90%, were mild sedations, with 2% moderate and 8% deep. Medicaid covered 84% of the sedations. The demand behind these numbers connects directly to childhood dental anxiety and untreated disease, a pattern explored in our dental anxiety and phobia statistics.

Source: High-risk medications in pediatric dentistry, JADA (2026)
See sedation record software
02 The Safety Picture
Pediatric sedation safety is best understood as a balance: for most children in well-run settings it is very safe, yet the consequences when something goes wrong can be severe. Both truths belong in the same picture.
On the reassuring side, a study of 7,041 office-based pediatric dental anesthesia cases performed by dentist anesthesiologists and tracked in the Society for Ambulatory Anesthesia registry found no cases of death, anaphylaxis, aspiration, or cardiovascular or neurologic complications. On the cautionary side, the 2026 MarketScan analysis found that about 4%, roughly 1 in 27, of pediatric sedation encounters were followed within a week by an emergency or urgent care visit or hospitalization, with 99% of those being emergency or urgent care visits and 1% hospitalizations. These measure different things, one tracks serious intraoperative complications and the other tracks any downstream healthcare visit, but together they frame the reality: serious harm is rare, minor downstream issues are not negligible, and outcomes depend heavily on the setting and the team.
It is common, but it is never low-stakes. The most serious adverse outcome of pediatric sedation is respiratory compromise, which can lead to hypoxemia and, rarely, catastrophic results, and reviews consistently find that most serious events are potentially avoidable. Historically, dental anesthesia deaths in children have clustered among 2- to 5-year-olds and in office settings, often involving providers with variable training. This is not a reason to avoid sedation, which safely enables essential care, but it is a firm reason to treat every pediatric sedation with rigorous monitoring, appropriate patient selection, and airway readiness.

Source: Office-Based Anesthesia: Safety and Outcomes in Pediatric Dental Patients (NCBI) | Trends in Death Associated with Pediatric Dental Sedation and GA (NCBI)
See how SedationVault supports safe sedation
03 Adverse Events and What They Are
Understanding the specific adverse events, and how widely their reported rates vary, is essential to reading pediatric sedation data honestly. The wide range in the literature reflects real differences in drugs, doses, and definitions.
A systematic review of 20 studies published between 2015 and 2024 found adverse event incidence ranging from 8% to 47.5%, reflecting how much the numbers depend on methodology. Within that range, the events break into categories of very different severity. Milder and more common events include agitation, reported as high as 47.5% in some studies, postoperative pain affecting up to 90% of children after general anesthesia, and nausea affecting around 19.6%. Serious but rarer events are dominated by the airway: laryngospasm at about 0.50% before discharge and post-discharge nausea around 5% in one detailed analysis. The clinical literature is consistent that the serious events are respiratory, and that vigilant intraoperative and postoperative monitoring is the key to catching them early.
Look at the two ends of the pediatric adverse-event data. Common events like agitation and postoperative discomfort can affect a large share of children, uncomfortable but rarely dangerous. Serious events like laryngospasm sit near half a percent, rare but potentially life-threatening. The gap between a nearly 50% ceiling on minor events and a roughly 0.5% floor on the dangerous ones is what makes monitoring indispensable: the job is not to prevent every whimper, it is to detect the rare respiratory event in time to act. That is a monitoring-and-documentation problem, and it is exactly why continuous vitals capture matters most in the smallest patients.
Sources: Adverse Events in Pediatric Dentistry systematic review (2025); 20-study pediatric review. Calculation and interpretation original to iSedate.

Source: Adverse Events in Pediatric Dental Anesthesia and Sedation, closed-claims review (PubMed)
See live vitals charting
04 Age and Risk Factors
One of the most useful findings in recent data is that pediatric sedation risk is not uniform across children. Certain groups carry measurably higher risk, which should inform patient selection and vigilance.
The 2026 MarketScan analysis found that adolescents aged 12 to 17 had more than 2.6 times the odds of an all-cause adverse outcome, and children with non-complex chronic conditions had more than double the odds, as did those covered by Medicaid. A separate cohort study of 2,548 sedated children found the highest adverse event rate, 12.2%, in those under one year of age, versus 9.7% in the 3- to 12-year group, identifying age as an independent risk factor. Historically, dental anesthesia mortality has concentrated among 2- to 5-year-olds. These findings do not point to a single "risky age" so much as to elevated vulnerability at both the youngest ages, for respiratory and physiologic reasons, and among older children and those with chronic conditions, for other reasons. Knowing this shapes who gets sedated, at what level, and with what precautions.

Source: Age-related characteristics of pediatric sedation adverse events, cohort study (NCBI)
See the sedation dentistry market overview
05 Methods Used in Children
The techniques used to sedate children mirror the adult toolkit but with pediatric-specific dosing and a strong preference for the lightest effective option. The choice reflects the child's age, anxiety, procedure, and health.
Nitrous oxide is a mainstay for mild pediatric anxiety, covered in depth in our nitrous oxide sedation statistics, while oral sedation, frequently oral midazolam around 0.75 mg/kg, is common for moderate cases and detailed further in our oral sedation dentistry statistics. Guidelines increasingly favor a combined nitrous-plus-midazolam technique for suitable patients, and combination approaches have been reported to improve success rates while demanding careful dosing to avoid deepening sedation unintentionally. For the most complex or uncooperative cases, deep sedation or general anesthesia by appropriately trained providers remains necessary. The consistent principle across pediatric guidelines is to use the lightest technique that will safely accomplish the needed care, escalating only when necessary.
In children, where the margin for error is smaller and the serious risks are respiratory, continuous monitoring and clear documentation are not optional extras, they are central to safe care. iSedate's SedationVault captures live vitals from compatible monitors, including Edan, MindRay, Criticare, and more (the Edan X10 is a common example), and builds a continuous, audit-ready record for every sedation case, so a pediatric team can watch trends in real time and demonstrate the standard of care afterward. For the broader market and demand context, see our sedation dentistry statistics overview.

Source: Systematic reviews on pediatric sedation in dentistry, umbrella review (NCBI)
Book a Demo
06 Summary Table: Every Statistic
| Statistic | Figure | Source | Year |
|---|---|---|---|
| Pediatric dental visits involving sedation meds | ~8% | JADA MarketScan analysis | 2026 |
| Children who received sedation | ~1.4 million | JADA MarketScan analysis | 2026 |
| Sedation encounters analyzed | ~2.8 million | JADA MarketScan analysis | 2026 |
| Mild sedation share | ~90% | JADA MarketScan analysis | 2026 |
| Deep sedation share | ~8% | JADA MarketScan analysis | 2026 |
| All-cause adverse outcome within 1 week | ~4% (1 in 27) | JADA MarketScan analysis | 2026 |
| Office-based cases with no serious complications | 7,041 (0 events) | SOAR registry study (NCBI) | 2017 |
| Reported adverse event range | 8-47.5% | Pediatric AE systematic review | 2025 |
| Agitation (upper reported rate) | ~47.5% | Pediatric AE systematic review | 2025 |
| Postoperative pain after GA (upper rate) | Up to 90% | Pediatric AE systematic review | 2025 |
| Nausea | ~19.6% | Pediatric AE systematic review | 2025 |
| Laryngospasm | ~0.50% | 20-study pediatric review | 2025 |
| Higher risk, ages 12-17 | OR 2.64 | JADA MarketScan analysis | 2026 |
| Higher risk, non-complex chronic conditions | OR 2.29 | JADA MarketScan analysis | 2026 |
| Adverse event rate, under 1 year | 12.2% | Age-related cohort study (NCBI) | 2024 |
| Optimal oral midazolam dose (pediatric) | 0.75 mg/kg | Pediatric sedation umbrella review | 2024 |
07 Frequently Asked Questions
How common is sedation in pediatric dentistry?
How safe is pediatric dental sedation?
What are the most common risks of sedating children?
Which children are at highest risk during sedation?
Is nitrous oxide or oral sedation used more in children?
All figures trace to peer-reviewed studies and large claims analyses. Adverse-event rates vary widely by drug, dose, definition, and setting, so they are presented with that context. The 2026 MarketScan analysis measures downstream healthcare visits (emergency, urgent care, hospitalization) rather than only intraoperative complications, which is a broader outcome measure. Sources include:
- "High-risk medications in pediatric dentistry," Suda et al., JADA (June 2026), MarketScan 2014-2019 analysis
- "Office-Based Anesthesia: Safety and Outcomes in Pediatric Dental Patients," SOAR registry, 7,041 cases (NCBI)
- "Adverse Events Associated with Sedation and General Anesthesia in Pediatric Dentistry: A Systematic Review" (JPMS, 2025)
- "Trends in Death Associated with Pediatric Dental Sedation and General Anesthesia" (NCBI)
- "Age-related characteristics of sedation in pediatric patients and their correlated adverse events: a cohort study" (NCBI)
- "Evaluating the Quality of Systematic Reviews on Pediatric Sedation in Dentistry: An Umbrella Review" (NCBI)
- Leelataweewud & Vann, "Adverse events and outcomes of conscious sedation for pediatric patients" (JADA)
In children, where the serious risks are respiratory and the margin is smaller, continuous monitoring and complete documentation are central to safe care. iSedate's SedationVault captures live vitals and builds an audit-ready record for every sedation case. To see how it works in your practice, book a demo.
























